Combination chemotherapy with cyclophosphamide, vincristine, and prednisolone (CVP) in TNM-classified stage IV mycosis fungoides

U. Tirelli, A. Carbone, A. Veronesi, E. Galligioni, M. G. Trovò, S. Tumolo, E. Grigoletto

Research output: Contribution to journalArticle

Abstract

Nine patients with stage IV mycosis fungoides (MF), according to TNM classification, were treated with cyclosphosphamide, vincristine, and prednisone (CVP). CVP induced a 66% overall objective response rate and a 44% complete response rate, which is the highest reported in the literature. CVP is an effective regimen in MF and could be employed in combination with total skin or total lymphoid radiotherapy. TNM classification should be used for all patients with MF, because it makes the evaluation and comparison of treatments more reliable.

Original languageEnglish
Pages (from-to)167-169
Number of pages3
JournalCancer Treatment Reports
Volume66
Issue number1
Publication statusPublished - 1982

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Combination chemotherapy with cyclophosphamide, vincristine, and prednisolone (CVP) in TNM-classified stage IV mycosis fungoides'. Together they form a unique fingerprint.

Cite this